The role of inflammation in the pathogenesis of age-related macular degeneration.

Age-related macular degeneration (AMD), the leading cause of blindness in the elderly, is a complex disease to study because of the potential role of demographic, environmental, and other systemic risk factors, such as age, sex, race, light exposure, diet, smoking, and underlying cardiovascular disease which may contribute to the pathogenesis of this disease. Recently, single nucleotide polymorphisms, DNA sequence variations found within the complement Factor H gene, have been found to be strongly associated with the development of AMD in Caucasians. One single nucleotide polymorphism, Tyr402His, was associated with approximately 50% of AMD cases. We review recent developments in the molecular biology of AMD, including single nucleotide polymorphisms within the Factor H gene, which may predispose individuals to the susceptibility of AMD as well as single nucleotide polymorphisms that may confer a protective effect. Taken together these findings help to provide new insights into the central issues surrounding the pathogenesis of AMD.

[1]  Wiklund Ra,et al.  First of two parts , 1997 .

[2]  J. Haines,et al.  Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. , 2004, American journal of human genetics.

[3]  R. Molday,et al.  Defective subunit assembly underlies a digenic form of retinitis pigmentosa linked to mutations in peripherin/rds and rom-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[5]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[6]  C. Mold,et al.  Regulation of complement activation by C-reactive protein. , 1999, Immunopharmacology.

[7]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[8]  Alexander J. Rivest,et al.  The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  V. Sheffield,et al.  Autosomal dominant macular dystrophy in a large Canadian family. , 2003, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[10]  M. Gillies,et al.  Immunological and Aetiological Aspects of Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[11]  V. Sheffield,et al.  A 2 base pair deletion in the RDS gene associated with butterfly-shaped pigment dystrophy of the fovea. , 1993, Human molecular genetics.

[12]  L. Donoso,et al.  X-linked retinoschisis: a clinical and molecular genetic review. , 2004, Survey of ophthalmology.

[13]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[14]  J. Heckenlively,et al.  Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. , 1999, American journal of ophthalmology.

[15]  S. Ranganathan,et al.  A common site within factor H SCR 7 responsible for binding heparin, C‐reactive protein and streptococcal M protein , 2003 .

[16]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Munnich,et al.  The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration , 1998 .

[18]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Robert B Sim,et al.  Two populations of complement factor H differ in their ability to bind to cell surfaces. , 1988, The Biochemical journal.

[20]  P. Green,et al.  Analysis of expressed sequence tags indicates 35,000 human genes , 2000, Nature Genetics.

[21]  V. Fischetti,et al.  M Protein of the Group A StreptococcusBinds to the Seventh Short Consensus Repeat of Human Complement Factor H , 1998, Infection and Immunity.

[22]  R. Nordquist,et al.  Immunological mimicry between retinal S-antigen and group A streptococcal M proteins. , 1995, Autoimmunity.

[23]  Paul Mitchell,et al.  Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. , 2003, Archives of ophthalmology.

[24]  R. Guymer,et al.  HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? , 2005, Survey of ophthalmology.

[25]  M. Blumenkranz,et al.  Risk factors in age-related maculopathy complicated by choroidal neovascularization. , 1986, Ophthalmology.

[26]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[27]  H. Soininen,et al.  Polymorphisms in neprilysin gene affect the risk of Alzheimer’s disease in Finnish patients , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  T. Dawber,et al.  Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. , 1978, American journal of ophthalmology.

[29]  S. Russell,et al.  Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  G. Ashwell,et al.  Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins. , 1971, The Journal of biological chemistry.

[31]  V. Fischetti,et al.  Identification of the Streptococcal M Protein Binding Site on Membrane Cofactor Protein (CD46)1 , 2002, The Journal of Immunology.

[32]  T. Dryja,et al.  Gene-based approach to human gene-phenotype correlations. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[34]  R. Klein,et al.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. , 2003, American journal of human genetics.

[35]  J. Tuo,et al.  Genetic factors of age-related macular degeneration , 2004, Progress in Retinal and Eye Research.

[36]  J. Haines,et al.  Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. , 2004, Molecular vision.

[37]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[38]  A. Hofman,et al.  Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.

[39]  C. Klaver,et al.  Evaluation of the ARMD1 locus on 1q25–31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1 , 2004, Ophthalmic genetics.

[40]  J. Rosenow,et al.  Malattia leventinese presenting with subretinal neovascular membrane and hemorrhage. , 2001, American journal of ophthalmology.

[41]  S. Meri,et al.  Factor H and disease: a complement regulator affects vital body functions. , 1999, Molecular immunology.

[42]  A. Kornzweig.  The eye in old age. V. Diseases of the macula: a clinicopathologic study. , 1965, American journal of ophthalmology.

[43]  L. Yannuzzi,et al.  Peripheral drusen in membranoproliferative glomerulonephritis type II. , 2003, Retina.

[44]  R. Klein,et al.  Early age-related maculopathy in the cardiovascular health study. , 2003, Ophthalmology.

[45]  J. Ott,et al.  Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. , 2004, Archives of ophthalmology.

[46]  Johanna M Seddon,et al.  The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.

[47]  A Hofman,et al.  Genetic risk of age-related maculopathy. Population-based familial aggregation study. , 1998, Archives of ophthalmology.

[48]  Robert B Sim,et al.  The complete amino acid sequence of human complement factor H. , 1988, The Biochemical journal.

[49]  M. Klein,et al.  Heredity and age-related macular degeneration. Observations in monozygotic twins. , 1994, Archives of ophthalmology.

[50]  K. Bønaa,et al.  Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study : The Tromsø Study. , 2001, American journal of epidemiology.

[51]  S. Hinrichs,et al.  Structural evidence for the authenticity of the human retinoblastoma gene. , 1987, Science.

[52]  Lee Wh,et al.  The molecular genetics of retinoblastoma. , 1990 .

[53]  I. McLean,et al.  Metastatic disease from untreated uveal melanomas. , 1979, American journal of ophthalmology.

[54]  Jennifer R. Evans,et al.  Risk Factors for Age-related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[55]  C. Owsley,et al.  The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study , 2005, British Journal of Ophthalmology.

[56]  S M Meyers,et al.  A twin study of age-related macular degeneration. , 1995, American journal of ophthalmology.

[57]  J. Nathans,et al.  What can we learn about age-related macular degeneration from other retinal diseases? , 1999, Molecular vision.

[58]  S. Santangelo,et al.  A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. , 2003, American journal of human genetics.

[59]  S. Fine,et al.  Prognosis of patients with bilateral macular drusen. , 1984, Ophthalmology.

[60]  S. Russell,et al.  Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. , 2000, American journal of ophthalmology.

[61]  W. Lee,et al.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.

[62]  A. Edwards,et al.  Clinical variability of Stickler syndrome: role of exon 2 of the collagen COL2A1 gene. , 2003, Survey of ophthalmology.

[63]  I. MacDonald,et al.  Ocular genetics: current understanding. , 2004, Survey of ophthalmology.

[64]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[65]  C. Osmond,et al.  Association of HLA class I and class II polymorphisms with age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.

[66]  S. Daiger,et al.  Identifying retinal disease genes: how far have we come, how far do we have to go? , 2004, Novartis Foundation symposium.

[67]  H. Rus,et al.  The role of complement activation in atherosclerosis , 2004, Immunologic research.

[68]  V. Sheffield,et al.  Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. , 1993, Archives of ophthalmology.

[69]  R. Klein,et al.  Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. , 1999, Archives of ophthalmology.

[70]  G. Gregoriadis,et al.  The role of sialic acid in determining the survival of glycoproteins in the circulation. , 1971, The Journal of biological chemistry.

[71]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[72]  Sander R. Dubovy,et al.  The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. , 2004, American journal of ophthalmology.

[73]  T. Matise,et al.  Age-related macular degeneration--a genome scan in extended families. , 2003, American journal of human genetics.

[74]  T. Dryja,et al.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. , 1994, Science.

[75]  A. Bird,et al.  Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. , 1993, The British journal of ophthalmology.

[76]  G. Remuzzi,et al.  Factor H family proteins: on complement, microbes and human diseases. , 2001, Biochemical Society transactions.

[77]  P. Jong.  Prevalence of age-related macular degeneration in the United States. , 2004 .

[78]  D M Hunt,et al.  The genetics of inherited macular dystrophies , 2003, Journal of medical genetics.

[79]  E Lai,et al.  Application of SNP technologies in medicine: lessons learned and future challenges. , 2001, Genome research.

[80]  R. Klein,et al.  Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. , 2003, Archives of ophthalmology.

[81]  G. Abecasis,et al.  Age-Related Macular Degeneration: A High-Resolution Genome Scan for Susceptibility Loci in a Population Enriched for Late-Stage Disease , 2004 .

[82]  A. Garrod.  The incidence of alkaptonuria: a study in chemical individuality. 1902 [classical article] , 1902, The Yale journal of biology and medicine.

[83]  A Hofman,et al.  Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.

[84]  J. Roider,et al.  Subretinale Neovaskularisationsmembranen bei Membranoproliferativer Glomerulonephritis Typ II , 1998 .

[85]  S. Rodríguez de Córdoba,et al.  The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.

[86]  A. Edwards,et al.  AUTOSOMAL DOMINANT PATTERN DYSTROPHY: Identification of a Novel Splice Site Mutation in the Peripherin/RDS Gene , 2005, Retina.

[87]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[88]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[89]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[90]  Z. Fishelson,et al.  Complement and apoptosis. , 2001, Molecular immunology.

[91]  C. Mold,et al.  C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. , 1984, Journal of immunology.

[92]  J. Ott,et al.  Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. , 2003, Archives of ophthalmology.

[93]  E. Johnsson,et al.  Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. , 1998, Journal of immunology.

[94]  F. Ferris,et al.  Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.

[95]  J. Weber,et al.  North Carolina macular dystrophy is assigned to chromosome 6. , 1992, Genomics.

[96]  P. Zipfel.  Complement Factor H: Physiology and Pathophysiology , 2001, Seminars in thrombosis and hemostasis.

[97]  S. Ranganathan,et al.  Multiple ligand binding sites on domain seven of human complement factor H. , 2001, International immunopharmacology.

[98]  A. Monaco,et al.  Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location. , 1986, Cold Spring Harbor symposia on quantitative biology.

[99]  L. Marmorstein.  Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review , 2004, Ophthalmic genetics.

[100]  I. MacDonald,et al.  Molecular genetics of inherited eye disorders. , 1994, Clinical and investigative medicine. Medecine clinique et experimentale.

[101]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[102]  A. Morell,et al.  The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins. , 1974, Biochemical Society symposium.

[103]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[104]  Johanna M Seddon,et al.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.

[105]  E. Traboulsi.  The challenges and surprises of studying the genetics of age-related macular degeneration. , 2005, American journal of ophthalmology.

[106]  K. Sandvig.  CENTRAL, AREOLAR CHOROIDAL ATROPHY , 1959, Acta ophthalmologica.

[107]  P. Delves,et al.  Advances in immunology: The immune system - Second of two parts. , 2000 .

[108]  V. Sheffield,et al.  Butterfly–shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene , 1993, Nature Genetics.

[109]  B. Lorenz,et al.  Positional cloning of the gene associated with X-linked juvenile retinoschisis , 1997, Nature Genetics.

[110]  R. Pruett,et al.  Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy , 1994, Nature Genetics.

[111]  J D Gass,et al.  Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.

[112]  Alexander J. Rivest,et al.  Characterization of β amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration , 2004 .

[113]  D. Colville,et al.  Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease"). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[114]  J. Forrester,et al.  Immunopathogenic mechanisms in intraocular inflammation. , 1999, Chemical immunology.

[115]  V. Sheffield,et al.  A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy , 1999, Nature Genetics.

[116]  K. Csaky,et al.  Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? , 2004, Archives of ophthalmology.

[117]  M. Margaglione,et al.  Apolipoprotein E Polymorphisms in Age-Related Macular Degeneration in an Italian Population , 2001, Ophthalmic Research.

[118]  M. Metzker,et al.  Identification of the gene responsible for Best macular dystrophy , 1998, Nature Genetics.

[119]  J. Haines,et al.  A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy , 2002, Ophthalmic genetics.

[120]  P. Delves,et al.  The Immune System , 2000 .

[121]  P. Crocker,et al.  The Sialoadhesins — A family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily , 1996, Glycoconjugate Journal.

[122]  R. Klein,et al.  Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye study , 1994, Genetic epidemiology.

[123]  Marco A Zarbin,et al.  Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[124]  J. Nathans,et al.  Genetic heterogeneity among blue-cone monochromats. , 1993, American journal of human genetics.

[125]  G. Silvestri.  Age-related macular degeneration: genetics and implications for detection and treatment. , 1997, Molecular medicine today.

[126]  P. Tolias,et al.  Functional cloning, sorting, and expression profiling of nucleic acid-binding proteins. , 2002, Genome research.

[127]  M L Bots,et al.  Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. , 1995, American journal of epidemiology.

[128]  J. Sahel,et al.  Case-control study of the risk factors for age related macular degeneration , 1998, The British journal of ophthalmology.

[129]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[130]  M. Botto.  Links between complement deficiency and apoptosis , 2001, Arthritis research.

[131]  M. C. Leske,et al.  Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. , 2000, Archives of ophthalmology.

[132]  J H Poynting.  ADDRESS TO THE MATHEMATICAL AND PHYSICAL SECTION. , 1899, Science.

[133]  Yan Shen,et al.  DSPP mutation in dentinogenesis imperfecta Shields type II , 2001, Nature Genetics.

[134]  A. Edwards,et al.  Autosomal dominant Stargardt-like macular dystrophy. , 2001, Survey of ophthalmology.

[135]  Alan Bird,et al.  Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy , 1993, Nature Genetics.

[136]  P. Mcgeer,et al.  Inflammation and the Degenerative Diseases of Aging , 2004, Annals of the New York Academy of Sciences.

[137]  V. Sheffield,et al.  Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.

[138]  P. Mitchell,et al.  Dietary fat and fish intake and age-related maculopathy. , 2000, Archives of ophthalmology.

[139]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[140]  T. Dryja,et al.  Dominant and digenic mutations in the peripherin/RDS and ROM1 genes in retinitis pigmentosa. , 1997, Investigative ophthalmology & visual science.

[141]  D. Lublin,et al.  Identification of complement regulatory domains in human factor H. , 1995, Journal of immunology.

[142]  T. Matise,et al.  Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.

[143]  U. H. Stroeher,et al.  The Human Complement Regulator Factor H Binds Pneumococcal Surface Protein PspC via Short Consensus Repeats 13 to 15 , 2002, Infection and Immunity.

[144]  M. Metzker,et al.  A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy , 2001, Nature Genetics.

[145]  M. Oppermann,et al.  Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology. , 2004, Histology and histopathology.

[146]  P. Delves,et al.  The immune system. Second of two parts. , 2000, The New England journal of medicine.

[147]  E. Rimm,et al.  Prospective study of alcohol consumption and the risk of age-related macular degeneration. , 2000, Archives of ophthalmology.

[148]  Jeffrey L. Anderson.  Infection, antibiotics, and atherothrombosis--end of the road or new beginnings? , 2005, The New England journal of medicine.

[149]  Association Between C-Reactive Protein and Age-Related Macular Degeneration , 2004 .

[150]  C. M. Davenport,et al.  Molecular genetics of human blue cone monochromacy. , 1989, Science.

[151]  A. Hofman,et al.  The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.

[152]  J. Lupski,et al.  A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.

[153]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[154]  T. L. McGee,et al.  Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. , 1990, The New England journal of medicine.

[155]  R. Klein,et al.  Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. , 2003, Ophthalmology.

[156]  M. Klein,et al.  Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. , 2003, Human molecular genetics.

[157]  G. Wildner,et al.  Autoimmune uveitis and antigenic mimicry of environmental antigens. , 2004, Autoimmunity reviews.

[158]  J. Davies,et al.  Modifier genes in cystic fibrosis , 2004, Pediatric pulmonology.

[159]  S. Fine,et al.  Age-related macular degeneration 1969-2004: a 35-year personal perspective. , 2005, American journal of ophthalmology.